Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiovascular Disease and Lipoprotein(a)”

124 trials

Showing 20 of 124 results

Not applicableStudy completedNCT02770872
What this trial is testing

The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk

Who this might be right for
Cardiovascular Disease
Lisa Tannock 19
Testing effectiveness (Phase 2)Study completedNCT04270760
What this trial is testing

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Who this might be right for
Cardiovascular Disease
Amgen 281
Not applicableStudy completedNCT03887520
What this trial is testing

Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

Who this might be right for
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals 49,001
Large-scale testing (Phase 3)Study completedNCT00092638
What this trial is testing

An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

Who this might be right for
HypercholesterolemiaCoronary Disease
Organon and Co 450
Large-scale testing (Phase 3)Active Not RecruitingNCT04023552
What this trial is testing

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Who this might be right for
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals 8,323
Large-scale testing (Phase 3)Active Not RecruitingNCT05900141
What this trial is testing

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Who this might be right for
Hyperlipoproteinemia (a)
Novartis Pharmaceuticals 41
Not applicableUnknownNCT05323227
What this trial is testing

Lp(a) With CCTA Assessed Parameters and Clinical Outcomes

Who this might be right for
Coronary Artery Disease
Shanghai Zhongshan Hospital 378
Not applicableUnknownNCT05330819
What this trial is testing

Thrombogenicity of Lipoprotein A: Laboratory Study Defining the Prothrombotic Effects of Lipoprotein A

Who this might be right for
Cardiovascular Disease and Lipid DisordersCardiac Disease
South Tees Hospitals NHS Foundation Trust 20
Large-scale testing (Phase 3)Looking for participantsNCT06597006
What this trial is testing

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia - Homozygous
Novartis Pharmaceuticals 9
Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Early research (Phase 1)Looking for participantsNCT06164730
What this trial is testing

VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

Who this might be right for
Heterozygous Familial HypercholesterolemiaPremature Coronary Heart Disease
Verve Therapeutics, Inc. 85
Not applicableStudy completedNCT01101230
What this trial is testing

Effects of Almonds on Cardiovascular Risk Factors

Who this might be right for
Cardiovascular Disease
Penn State University 61
Not applicableStudy completedNCT02091583
What this trial is testing

Canola Oil, Fibre and DHA Enhanced Clinical Trial

Who this might be right for
Metabolic Syndrome
University of Manitoba 30
Testing effectiveness (Phase 2)Ended earlyNCT01004705
What this trial is testing

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

Who this might be right for
Elevated LDL Cholesterol
Ferrer Internacional S.A. 36
Not applicableStudy completedNCT03273972
What this trial is testing

INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers

Who this might be right for
AtherosclerosisCardiovascular Diseases
Cambridge University Hospitals NHS Foundation Trust 30
Not applicableUnknownNCT06297239
What this trial is testing

Argentine Registry of Lp(a)

Who this might be right for
Lp(A)HypercholesterolemiaCardiovascular Diseases+2 more
School of Medicine. National University of Cuyo 1,000
Not applicableStudy completedNCT07023445
What this trial is testing

Patterns of Inclisiran Use in the Real World: An Analysis of US Databases

Who this might be right for
Atherosclerotic Cardiovascular DiseaseFamilial Hypercholesterolemia
Novartis Pharmaceuticals 37,688
Not applicableUnknownNCT05090878
What this trial is testing

Atherogenic Lipoproteins in Ischemic Stroke

Who this might be right for
Ischemic Stroke
University Hospital, Basel, Switzerland 500
Not applicableStudy completedNCT01889368
What this trial is testing

Effect of a Grape Seed Extract (GSE) on Insulin Resistance

Who this might be right for
Metabolic Syndrome
University of California, Davis 19
Not applicableLooking for participantsNCT06995183
What this trial is testing

Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Identified Through Family Screening

Who this might be right for
Lipoprotein(a)
E.S.stroes 150
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation